HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sabine Brandt Selected Research

Cold Shock Proteins and Peptides

11/2018Cold shock Y-box binding protein-1 acetylation status in monocytes is associated with systemic inflammation and vascular damage.
4/2018Crosstalk between Akt signaling and cold shock proteins in mediating invasive cell phenotypes.
11/2017Inflammatory cell infiltration and resolution of kidney inflammation is orchestrated by the cold-shock protein Y-box binding protein-1.
12/2016A remedy for kidney disease successfully alters the cold shock protein response during inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sabine Brandt Research Topics

Disease

11Infections
02/2022 - 11/2001
10Neoplasms (Cancer)
02/2022 - 01/2014
6Inflammation (Inflammations)
10/2019 - 06/2005
3Digital Dermatitis
01/2022 - 03/2011
3Coinfection
03/2010 - 07/2007
2Neoplasm Metastasis (Metastasis)
02/2022 - 09/2019
2Fibrosis (Cirrhosis)
11/2020 - 11/2012
2Kidney Diseases (Kidney Disease)
12/2016 - 08/2016
2Melanoma (Melanoma, Malignant)
01/2015 - 12/2004
1Chronic Kidney Failure (Chronic Renal Failure)
09/2022
1Squamous Cell Carcinoma of Head and Neck
06/2022
1Sepsis (Septicemia)
05/2022
1Disease Progression
02/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
01/2022
1Treponemal Infections (Bejel)
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Dermatitis
01/2022
1Weight Gain
10/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2021
1Human Influenza (Influenza)
01/2021
1Diabetes Mellitus
10/2019
1Cardiovascular Diseases (Cardiovascular Disease)
10/2019
1Type 2 Diabetes Mellitus (MODY)
10/2019
1Atherosclerosis
11/2018
1Renal Cell Carcinoma (Grawitz Tumor)
04/2018
1Wounds and Injuries (Trauma)
01/2018
1Acute Kidney Injury (Acute Renal Failure)
08/2016
1Chronic Renal Insufficiency
08/2016
1Ovarian Neoplasms (Ovarian Cancer)
01/2016
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2015
1Ulcer
09/2015
1Persistent Infection
01/2015
1Lyme Disease (Disease, Lyme)
04/2012
1Stomach Neoplasms (Stomach Cancer)
04/2012
1Eosinophilia
07/2011

Drug/Important Bio-Agent (IBA)

6DNA (Deoxyribonucleic Acid)IBA
06/2022 - 03/2011
6Proteins (Proteins, Gene)FDA Link
03/2014 - 06/2005
4Cold Shock Proteins and PeptidesIBA
11/2018 - 12/2016
3Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2016
3Biological ProductsIBA
01/2022 - 12/2004
37,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
01/2022 - 03/2011
3AntigensIBA
01/2021 - 04/2012
3VaccinesIBA
12/2015 - 10/2009
2Keratins (Keratin)IBA
02/2022 - 01/2014
2Notch3 ReceptorIBA
11/2020 - 11/2012
2Y-Box-Binding Protein 1IBA
01/2016 - 01/2014
2AntibodiesIBA
04/2012 - 10/2009
2Interleukin-8 (Interleukin 8)IBA
01/2011 - 06/2005
2Serine (L-Serine)FDA Link
10/2009 - 08/2009
1MidkineIBA
09/2022
1Muramidase (Lysozyme)IBA
05/2022
1EnzymesIBA
05/2022
1Pancreatic Elastase (Elastase)IBA
05/2022
1Peroxidase (Myeloperoxidase)IBA
05/2022
1CateninsIBA
02/2022
1Adapalene (Differin)FDA LinkGeneric
02/2022
1VimentinIBA
02/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2022
1Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric
01/2022
1Ointments (Pastes)IBA
01/2022
1SaltsIBA
10/2021
1InterferonsIBA
01/2021
1RNA Splicing FactorsIBA
12/2020
1oxidized low density lipoproteinIBA
10/2019
1AlbuminsIBA
10/2019
1CreatinineIBA
10/2019
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
10/2019
1LDL Lipoproteins (beta Lipoproteins)IBA
10/2019
1Angiopoietin-2IBA
10/2019
1MART-1 AntigenIBA
09/2019
1Lysine (L-Lysine)FDA Link
11/2018
14,5-dibromo-2-pyrrolic acidIBA
04/2018
1Macrophage Colony-Stimulating FactorIBA
08/2016
1Messenger RNA (mRNA)IBA
12/2015
1Immune Sera (Antisera)IBA
12/2015
1Therapeutic UsesIBA
01/2015
1Indicators and Reagents (Reagents)IBA
01/2015
1NucleotidesIBA
01/2015
1Circulating Tumor DNAIBA
01/2015
1AutoantibodiesIBA
03/2014
1big gastrinIBA
01/2014
1Peptides (Polypeptides)IBA
01/2014
1Phosphopyruvate Hydratase (Enolase)IBA
01/2014
1beta 2-Microglobulin (beta 2 Microglobulin)IBA
01/2014
1Carcinoembryonic AntigenIBA
01/2014
1squamous cell carcinoma-related antigenIBA
01/2014
1Thymidine KinaseIBA
01/2014
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2014
1Tumor Biomarkers (Tumor Markers)IBA
01/2014
1Tissue Polypeptide AntigenIBA
01/2014
1Immunoglobulin G (IgG)IBA
04/2012
1Oncogene Proteins (Oncogene Protein)IBA
04/2012
1Immunoglobulin M (IgM)IBA
04/2012
1AllergensIBA
07/2011
1Immunoglobulin E (IgE)IBA
07/2011

Therapy/Procedure

4Therapeutics
02/2022 - 01/2015
2Renal Dialysis (Hemodialysis)
09/2022 - 11/2018
1Drug Therapy (Chemotherapy)
01/2022
1Immunotherapy
01/2021
1Autologous Transplantation
01/2018